We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$356M
AUM Growth
+$21.4M
Cap. Flow
+$13.5M
Cap. Flow %
3.78%
Top 10 Hldgs %
21.9%
Holding
167
New
14
Increased
82
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$6.43M
2
SLB icon
SLB Ltd
SLB
+$3.78M
3
PETM
PETSMART INC
PETM
+$3.64M
4
TSM icon
TSMC
TSM
+$3.11M
5
TM icon
Toyota
TM
+$2.51M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.53M
2
KDP icon
Keurig Dr Pepper
KDP
+$4.88M
3
FFIV icon
F5
FFIV
+$3.47M
4
CA
CA, Inc.
CA
+$2.97M
5
MDT icon
Medtronic
MDT
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 12.43%
3 Industrials 12.11%
4 Energy 9.92%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.08T
$5.1M 1.43%
183,606
+884
+0.5% +$25.7K
IBM icon
27
IBM
IBM
$209B
$4.91M 1.38%
26,676
-808
-3% -$142K
CTSH icon
28
Cognizant
CTSH
$24.3B
$4.9M 1.38%
96,890
+898
+0.9% +$44.9K
CXW icon
29
CoreCivic
CXW
$2.95B
$4.89M 1.37%
156,053
+7,903
+5% +$261K
MDT icon
30
Medtronic
MDT
$110B
$4.66M 1.31%
75,690
-34,862
-32% -$2.03M
UNH icon
31
UnitedHealth
UNH
$383B
$4.61M 1.29%
56,165
+979
+2% +$73.7K
SLB icon
32
SLB Ltd
SLB
$72.6B
$4.53M 1.27%
46,418
+41,818
+909% +$3.78M
BA icon
33
Boeing
BA
$175B
$4.46M 1.25%
35,546
+1,655
+5% +$216K
ESRX
34
DELISTED
Express Scripts Holding Company
ESRX
$4.3M 1.21%
57,325
+470
+0.8% +$35.2K
AAP icon
35
Advance Auto Parts
AAP
$3.39B
$4.14M 1.16%
32,736
-647
-2% -$78.5K
DTV
36
DELISTED
DIRECTV COM STK (DE)
DTV
$4.13M 1.16%
53,985
+1,012
+2% +$74.2K
VZ icon
37
Verizon
VZ
$193B
$3.91M 1.1%
82,182
+11,750
+17% +$556K
TUP
38
DELISTED
Tupperware Brands Corporation
TUP
$3.84M 1.08%
45,879
+5,314
+13% +$437K
DLTR icon
39
Dollar Tree
DLTR
$24.7B
$3.81M 1.07%
73,081
+1,415
+2% +$75.3K
PETM
40
DELISTED
PETSMART INC
PETM
$3.78M 1.06%
+54,898
New +$3.64M
BEN icon
41
Franklin Resources
BEN
$17.2B
$3.76M 1.06%
69,480
+6,696
+11% +$360K
MPC icon
42
Marathon Petroleum
MPC
$91.7B
$3.76M 1.06%
86,318
+4,184
+5% +$183K
SNI
43
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$3.69M 1.04%
48,628
+410
+0.9% +$31.9K
INFY icon
44
Infosys
INFY
$48.4B
$3.62M 1.02%
534,784
+12,560
+2% +$91.2K
RHI icon
45
Robert Half
RHI
$3.81B
$3.58M 1.01%
85,337
-577
-0.7% -$23.8K
TSM icon
46
TSMC
TSM
$2.09T
$3.47M 0.98%
+173,485
New +$3.11M
RMD icon
47
ResMed
RMD
$30.3B
$3.44M 0.97%
76,996
+8,123
+12% +$365K
T icon
48
AT&T
T
$159B
$3.36M 0.94%
126,739
+8,764
+7% +$220K
GE icon
49
GE Aerospace
GE
$368B
$3.34M 0.94%
26,945
-368
-1% -$45.5K
SPN
50
DELISTED
Superior Energy Services, Inc.
SPN
$3.34M 0.94%
10,857
+775
+8% +$208K

Similar funds

Grimes & Company's Q1 2014 Portfolio in Review

As of Q1 2014, Grimes & Company held 167 positions worth $356M, up 6.4% from $335M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Grimes & Company deployed $13.5M of net new capital in Q1 2014, opening 14 new positions and adding to 82 existing holdings. Its largest new stake was Gen Digital: 300,398 shares worth $6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AstraZeneca, an estimated $6.53M trimmed.

  • Grimes & Company's largest Q1 2014 buy was Gen Digital: 300,398 shares worth $6M.
  • Grimes & Company added most to SLB Ltd in Q1 2014, an estimated $3.78M increase.
  • Grimes & Company's biggest Q1 2014 reduction was AstraZeneca, cutting an estimated $6.53M.
  • Grimes & Company fully exited F5 in Q1 2014, selling an estimated $3.47M.
  • Grimes & Company's ten largest holdings make up 22% of its $356M portfolio in Q1 2014.
  • Grimes & Company opened 14 new positions and closed 17 in Q1 2014.
  • Grimes & Company's portfolio value rose 6.4% quarter-over-quarter to $356M.

Based on Grimes & Company's 13F filing for Q1 2014, filed 1 May 2014.